Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

BUY
$34.17 - $47.91 $75,515 - $105,881
2,210 New
2,210 $0
Q1 2022

Apr 27, 2022

SELL
$30.32 - $91.33 $149,174 - $449,343
-4,920 Closed
0 $0
Q4 2021

Jan 31, 2022

SELL
$86.26 - $119.0 $350,991 - $484,211
-4,069 Reduced 45.27%
4,920 $459,000
Q3 2021

Nov 03, 2021

SELL
$100.17 - $126.36 $644,894 - $813,505
-6,438 Reduced 41.73%
8,989 $1 Million
Q2 2021

Jul 30, 2021

SELL
$86.05 - $119.72 $270,627 - $376,519
-3,145 Reduced 16.93%
15,427 $1.75 Million
Q1 2021

Apr 29, 2021

SELL
$91.47 - $124.36 $180,287 - $245,113
-1,971 Reduced 9.59%
18,572 $1.89 Million
Q4 2020

Jan 28, 2021

SELL
$66.66 - $111.74 $339,299 - $568,756
-5,090 Reduced 19.86%
20,543 $2.04 Million
Q3 2020

Oct 29, 2020

SELL
$45.89 - $72.67 $354,408 - $561,230
-7,723 Reduced 23.15%
25,633 $1.85 Million
Q2 2020

Jul 24, 2020

SELL
$26.36 - $49.86 $184,203 - $348,421
-6,988 Reduced 17.32%
33,356 $1.66 Million
Q1 2020

Apr 29, 2020

BUY
$17.27 - $40.17 $28,754 - $66,883
1,665 Added 4.3%
40,344 $1.21 Million
Q3 2019

Oct 28, 2019

SELL
$25.38 - $34.89 $336,894 - $463,129
-13,274 Reduced 25.55%
38,679 $1.27 Million
Q2 2019

Jul 30, 2019

BUY
$17.75 - $27.58 $405,871 - $630,644
22,866 Added 78.61%
51,953 $1.43 Million
Q1 2019

Apr 30, 2019

BUY
$11.34 - $20.62 $329,846 - $599,773
29,087 New
29,087 $600,000
Q4 2018

Feb 01, 2019

SELL
$12.32 - $24.38 $143,109 - $283,198
-11,616 Closed
0 $0
Q3 2018

Nov 05, 2018

SELL
$18.82 - $28.96 $307,707 - $473,496
-16,350 Reduced 58.46%
11,616 $278,000
Q2 2018

Jul 30, 2018

BUY
$8.79 - $19.98 $245,821 - $558,760
27,966 New
27,966 $526,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.